Please login to the form below
Namenda
This page shows the latest Namenda news and features for those working in and with pharma, biotech and healthcare.
Forest said to be interested in $3bn Aptalis acquisition
US for former blockbuster antidepressant Lexapro (escitalopram), as well as generic competition from 2015 for Alzheimer's disease therapy Namenda (memantine). ... With Lexapro and Namenda accounting for more than three quarters of company turnover at
Latest news
-
Lundbeck and Otsuka take Alzheimer's drug into phase III
Regardless, it has been 10 years since the last new Alzheimer's treatment reached the market - Lundbeck's glutamate (NMDA) antagonist Ebixa (memantine), which is sold as Namenda by Forest Labs
-
Forest's net income down for Q3
He said: "We have been working diligently for the past seven years to build a solid product development pipeline that will more than replace the loss of Lexapro and Namenda following
-
Forest Laboratories earnings rise
Lexapro (escitalopram) and its Alzheimer's drug Namenda (memantine) lose their patent protection in the coming years. . ... expiration for both Lexapro in 2012 and Namenda in 2015 and provide growth," he said.
-
Lifting the fog
Additionally, a patch formulation of donepezil is in development. Also approved for the treatment of moderate-to-severe AD is memantine (Namenda, Forest Laboratories), which was the first NMDA receptor antagonist
-
Forest Labs earnings fall in Q2
revenues lost due to patent expiration for Lexapro in 2012 and [the Alzheimer's drug] Namenda (memantine) in 2015.".
More from news
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest Intelligence
-
Pharma deals during January 2014
Not disclosed. Adamas. Forest. Completion of studies for the NDA of a fixed dosed combination of Namenda and donepezil, Forest has exclusive US commercialisation rights.
-
Pharma deals during November 2012
Development / commercialisation. Fixed dose combination of Namenda and donepezil for AD.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Regeneron seeks US emergency use authorisation for COVID-19 antibody cocktail
- Send Us a Message
- The Truth about Doctors
- Eli Lilly’s COVID-19 antibody trial paused due to safety issue
- UK scientists begin testing BCG vaccine for severe COVID-19 protection
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- Pfizer CEO pushes back COVID-19 vaccine submission to November
- WHO trial casts doubt on remdesivir's efficacy
- Galapagos mid-stage trial failure raises concerns for Gilead deal
- How Far Do You Want To Go?
- Every superhero has an origin story – what’s yours?
- Live Webinar: Solving the Caregiver Crisis Through Technology
PMHub
Empowering Strategic Performance Ltd
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...
Latest intelligence
- How Far Do You Want To Go?
- Join OPEN Health's virtual careers event on Tuesday 10th November, 15:00–17:00 GMT and discover where a career in medical communications could take you…...
- "Fishbowl" Web Meeting for Internal POA Discussions: a Customer Story
- Learn how our client successfully carried out a set of three virtual plan of action (POA) discussions, including one internal “Fishbowl” web meeting....
- Whats the difference between patient engagement and patient experience?
- We all talk a lot about patient engagement and patient experience. And sometimes, these terms are used interchangeably across the industry. But while they’re both important, they’re not the same....
Quick links
Infographics
